Dark Skies For Ocaliva: US FDA Sides With AdComm In Complete Response Letter

 
• By Bridget Silverman
  
Storms may be on the horizon for Intercept after Ocaliva received a complete response letter from the FDA in primary biliary cholangitis. (Shutterstock)

More from Complete Response Letters

More from Geography